BioStorage Technologies Expands Liquid Nitrogen Storage in Germany-based Biorepository Facility

INDIANAPOLIS, Oct. 10, 2011 /PRNewswire/ — BioStorage Technologies, a global
provider of comprehensive sample asset management, biomaterial storage and cold
chain logistics for the bioscience industry, today announced the expansion of
its temperature-controlled storage options to include vapor-phase liquid
nitrogen preservation at its state-of-the-art biorepository facility in
Griesheim, Germany.

The expansion of vapor phase liquid nitrogen storage allows BioStorage
Technologies to offer the widest range of storage options available in the
industry. The company’s temperature-controlled storage options include: bulk
sample storage at 15 degrees Celsius to 27 degrees Celsius, cold sample storage
at -20 degrees Celsius and 5 degrees Celsius, and ultra-low temperature storage
at -70 degrees Celsius and -80 degrees Celsius, and liquid nitrogen storage -190
degrees Celsius. To ensure biomaterial assets are stored at the precise
temperature, samples are continuously monitored and tracked by BioStorage’s
proprietary ISISS® technology, thereby providing a regulatory audit trail of
location and movement of each sample within our facility.

“To meet the needs of our expanding client base and the growing need for
biopreservation of cellular-based samples, we expanded vapor-phase liquid
nitrogen storage capability in our Germany based operations, which provides our
European clients with the full range of storage conditions they require for
specimen preservation, ranging from -190 degrees Celsius to controlled room
temperature storage,” said Russ Hager, Senior Director of Global Biorepository
Operations, BioStorage Technologies. “Integrating this expanded liquid nitrogen
storage capability into our current processes gives our customers greater
flexibility in meeting their long-term storage needs without sacrificing the
level of quality and sample management they require.”

BioStorage Technologies manages the complete life cycle of a sample from
planning, collection, transportation, protection and retrieval to sample
disposal. The company serves pharmaceutical and biotech firms, donor
organizations and tissue banks, as well as research and academic organizations
around the world. BioStorage Technologies maintains US FDA 21 CFR Part 11
compliant validated technology and tracking systems and adheres to global
regulatory agency guidelines and regulations, as well as International Air
Transport Association logistics certification and guidelines and US Department
of Transportation guidelines.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is the premier, global provider of comprehensive
sample management solutions for the bioscience industry. Offering onsite or
outsourced management of sample assets, BioStorage Technologies manages the
complete life cycle of samples. With a team of global sample experts,
state-of-the-art temperature-controlled storage facilities, and a real-time,
web-based sample intelligence and tracking system, the company supports
customers in maximizing opportunities, minimizing risk and reducing the cost of
sample management. BioStorage Technologies, Inc. is privately held and
headquartered in Indianapolis with an additional full-service site near
Frankfurt, Germany. For more information, visit www.biostorage.com or call +1
(866) 697-2675 or +49-6155-898-1011.

Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
michael@millerbrooks.com

SOURCE BioStorage Technologies, Inc.